류마티스 관절염 진단에 있어서 항-Cyclic Citrullinated Peptide 항체와류마티스인자의 진단적 가치 비교 평가
A Comparative Evaluation of the Diagnostic Value of Anti-cyclic Citrullinated Peptide andRheumatoid Factor in Rheumatoid Arthritis
2
조회
0
다운로드
2
인용
0
참고문헌
초록
Abstract
Background : Despite its unsatisfactory specificity, rheumatoid factor (RF) is the only serologic marker included in the diagnostic criteria of the American College of Rheumatology (ACR) for rheumatoid arthritis. Recently, the diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies has been emphasized in rheumatoid arthritis (RA) due to its high specificity. To evaluate the second generation of anti-CCP antibodies as a diagnostic marker, we evaluated anti-CCP test in 163 individuals. Methods : The study population was divided into the following four groups: RA group (n=18), other disease group with arthritic symptoms (n=44), other disease group without arthritic symptoms (n=45), and healthy group (n=56). Anti-CCP was measured by an ELISA analyzer (Coda, Bio-Rad, USA) with Immunoscan RA (Euro-Diagnostica, Malmo, Sweden) and RF was measured by an automated chemistry analyzer (Toshiba, Japan) with RF-LATEX X1 (Denka Seiken, Japan). Results : The sensitivity of anti-CCP and RF was 72.2% and 100%, respectively, and the respective figures for the specificity were 96.6% and 73%. On each ROC curve, the area under the curve was 0.867 for anti-CCP and 0.959 for RF. In other disease groups, most of the false positive cases of RF were found in the patients with hyperlipidemia or HBV carriage. However, anti-CCP was not detected in any of the patients with these two conditions. False positive rates of RF in the three control groups were 34.1% in other disease group with arthritic symptoms, 48.9% in the other disease group without arthritic symptoms, and 3.6% in healthy group. The respective figures for anti-CCP were 6.8%, 2.2%, and 1.8%. Conclusions : The specificity of anti-CCP antibodies was higher than that of RF for discriminating RA from other diseases, especially in the patients with hyperlipidemia or HBV carriage. With its high specificity, anti-CCP antibodies can play an additive role in establishing the diagnosis of RA in patients with RF positivity. (Korean J Lab Med 2008;28:39-45)
참고문헌 (18)
- Kasper, D.L., "Harrison’s principles of internal medicine", pp.1968~1976 (2004), McGraw-Hill
- Bombardieri, M., "Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement", Arthritis Res Ther, 6, pp.R137~R141 (2004)
- Goldbach-Mansky, R., "Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset", Arthritis Res, 2, pp.236~243 (2000)
- 최석우, "류마티스 관절염 환자에서 ANti-Cyclic Citrullinated Peptide Antibodies검사의 진단적 유용성", Annals of Laboratory Medicine, 23(2), pp.132~138 (2003), 대한진단검사의학회
- Schellekens, G.A., "The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide", Arthritis Rheum, 43, pp.155~163 (2000)
- Vallbracht, I., "Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis", Autoimmun Rev, 4, pp.389~394 (2005)
- Boers, M., "Randomised comparison of combined stepdown prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis", Lancet, 350, pp.309~318 (1997)
- Rose, N.R., "Manual of clinical laboratory immunology", pp.659~664 (2002), ASM press
- Choi Suk Woo, "Diagnostic Performances of Anti-Cyclic Citrullinated Peptides Antibody and Antifilaggrin Antibody in Korean Patients with Rheumatoid Arthritis", Journal of Korean Medical Science, 20(3), pp.473~478 (2005), 대한의학회
- Kang, H.J., "Diagnostic usefulness of the anticyclic citrullinated peptide antibodies for rheumatoid arthritis", J Korean Rheum Assoc, 10, pp.117~125 (2003)
- 김경희, "Anti-cyclic Citrullinated Peptide Antibody 검사의 임상적 유용성", Annals of Laboratory Medicine, 23(6), pp.405~410 (2003), 대한진단검사의학회
- Kaplan, L.A., "Clinical chemistry : theory, analysis, correlation", pp.427~428 (1996), Mosby
- Lee, D.M., "Clinical utility of the anti-CCP assay in patients with rheumatic diseases", Ann Rheum Dis, 62, pp.870~874 (2003)
- Vallbracht, I., "Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis", Ann Rheum Dis, 63, pp.1079~1084 (2004)
- Nielen, M.M., "Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis", Ann Rheum Dis, 64, pp.1199~1204 (2005)
- Avouac, J., "Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review", Ann Rheum Dis, 65, pp.845~851 (2006)
- Meyer, O., "Cantagrel A, Dubois A, et al. Anticitrullinated protein", peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage, 2003, pp.62, 120~126
- Kroot, E.J., "The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis", Arthritis Rheum, 43, pp.1831~1835 (2000)